BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32479245)

  • 1. Tuning Down the Pain - An Overview of Allosteric Modulation of Opioid Receptors: Mechanisms of Modulation, Allosteric Sites, Modulator Syntheses.
    Bartuzi D; Wróbel TM; Kaczor AA; Matosiuk D
    Curr Top Med Chem; 2020; 20(31):2852-2865. PubMed ID: 32479245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Positive Allosteric Modulators of µ Opioid Receptor-Insight from In Silico and In Vivo Studies.
    Bartuzi D; Kędzierska E; Kaczor AA; Schmidhammer H; Matosiuk D
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics.
    Remesic M; Hruby VJ; Porreca F; Lee YS
    ACS Chem Neurosci; 2017 Jun; 8(6):1147-1158. PubMed ID: 28368571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric Modulation of Opioid G-Protein Coupled Receptors by Sigma
    Pasternak GW
    Handb Exp Pharmacol; 2017; 244():163-175. PubMed ID: 28667477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allostery at opioid receptors: modulation with small molecule ligands.
    Livingston KE; Traynor JR
    Br J Pharmacol; 2018 Jul; 175(14):2846-2856. PubMed ID: 28419415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dualism, allosteric modulation, and biased signaling of opioid receptors: Future therapeutic potential.
    González AM; Jubete AG
    Rev Esp Anestesiol Reanim (Engl Ed); 2024 Apr; 71(4):298-303. PubMed ID: 37683976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Untangling the complexity of opioid receptor function.
    Valentino RJ; Volkow ND
    Neuropsychopharmacology; 2018 Dec; 43(13):2514-2520. PubMed ID: 30250308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposed Mode of Binding and Action of Positive Allosteric Modulators at Opioid Receptors.
    Shang Y; Yeatman HR; Provasi D; Alt A; Christopoulos A; Canals M; Filizola M
    ACS Chem Biol; 2016 May; 11(5):1220-9. PubMed ID: 26841170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation and Allosteric Modulation of Human μ Opioid Receptor in Molecular Dynamics.
    Bartuzi D; Kaczor AA; Matosiuk D
    J Chem Inf Model; 2015 Nov; 55(11):2421-34. PubMed ID: 26517559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of the Na+ ion binding site as a mechanism for positive allosteric modulation of the mu-opioid receptor.
    Livingston KE; Traynor JR
    Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18369-74. PubMed ID: 25489080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of allosteric probe dependence in μ opioid receptor.
    Bartuzi D; Kaczor AA; Matosiuk D
    J Biomol Struct Dyn; 2019 Jan; 37(1):36-47. PubMed ID: 29241414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights from molecular dynamics simulations to exploit new trends for the development of improved opioid drugs.
    Filizola M
    Neurosci Lett; 2019 May; 700():50-55. PubMed ID: 29466721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of natural product regulation of opioid receptors in the treatment of human disease.
    Badal S; Turfus S; Rajnarayanan R; Wilson-Clarke C; Sandiford SL
    Pharmacol Ther; 2018 Apr; 184():51-80. PubMed ID: 29097308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid Receptors.
    Stein C
    Annu Rev Med; 2016; 67():433-51. PubMed ID: 26332001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New opioid receptor modulators and agonists.
    Kaye AD; Cornett EM; Patil SS; Gennuso SA; Colontonio MM; Latimer DR; Kaye AJ; Urman RD; Vadivelu N
    Best Pract Res Clin Anaesthesiol; 2018 Jun; 32(2):125-136. PubMed ID: 30322454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid Receptors and Protonation-Coupled Binding of Opioid Drugs.
    Lešnik S; Bertalan É; Bren U; Bondar AN
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of selective agonists and positive allosteric modulators for µ- and δ-opioid receptors from a single high-throughput screen.
    Burford NT; Wehrman T; Bassoni D; O'Connell J; Banks M; Zhang L; Alt A
    J Biomol Screen; 2014 Oct; 19(9):1255-65. PubMed ID: 25047277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Central and peripheral mechanisms in antinociception: current and future perspectives].
    Fürst Z
    Neuropsychopharmacol Hung; 2008 Jun; 10(3):127-30. PubMed ID: 18956616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New vistas in opioid control of pain.
    Mizoguchi H; Watanabe C; Sakurada T; Sakurada S
    Curr Opin Pharmacol; 2012 Feb; 12(1):87-91. PubMed ID: 22104733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of receptor allosterism.
    Gregory KJ; Sexton PM; Christopoulos A
    Curr Protoc Pharmacol; 2010 Dec; Chapter 1():Unit 1.21. PubMed ID: 21935895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.